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Abstract
Complex hepatitis B virus (HBV) variants with mutations in core promoter (Cp) plus deletions in the C gene and/or preS region – that are
associated with development of liver cirrhosis in renal transplant recipients – show a drastically changed phenotype with altered transcription and
disturbed surface and core protein expression. Here, we analyzed the replication phenotype of six different defective variant genomes, isolated
from two patients, after co-transfection with HBV wild-type (wt) in varying proportions. Both in HuH7 and HepG2 cells, the variants showed
enhanced replication and enrichment in the different transfected variant-wt mixtures. Contrary to artificial variants with only C gene deletions in
wt context, the original complex variants as well as wt genomes carrying C gene and Cp mutations of the variants did mostly not suppress wt
replication. Thus, the Cp mutations compensate the suppression of wt by C gene deletions and furthermore enhance the replication level.
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In long-term immunosuppressed renal transplant recipients
that are chronically infected with hepatitis B virus (HBV), the
development of liver cirrhosis (LC) and end-stage liver disease is
associated with the accumulation and persistence of HBV
variants exhibiting a distinct complex mutation pattern. The
variants are characterized by deletions/insertions in core pro-⁎ Corresponding author. Fax: +49 30 450525908.
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doi:10.1016/j.virol.2007.10.039moter (Cp), deletions in C gene and sometimes deletions in preS
(Preikschat et al., 2002). The fact that the usual immune
mediated liver injury induced by the non-cytopathogenic HBV
wild-type (wt) seems unlikely in renal transplant recipients,
suggests a role of these complex variants in pathogenesis. Like
other variants with internal deletions in C gene, the complex
variants are defective for autonomous replication (Märschenz
et al., 2006; Okamoto et al., 1993; Yuan et al., 1998b). However,
their genome replication can be rescued by non-deleted wt core
protein provided in trans from an expression plasmid or from
complete wt virus (Günther et al., 2000; Märschenz et al., 2006;
Yuan et al., 1998b). Additionally, for secretion of complete virus
particles, many complex variants need complementation with wt
surface proteins due to their multiple mutations in S gene
(Märschenz et al., 2006). Consequently, in the renal transplant
recipients, wt-like virus always remained present during accu-
mulation of the complex variants. Yet, the proportion of ge-
nomes with a wt C gene continuously decreased in the clinical
course, sometimes to levels as low as 10% of the HBV popu-
lation during end-stage liver disease (Preikschat et al., 2002).
248 S. Märschenz et al. / Virology 372 (2008) 247–259In extensive functional analyses of representative complete
HBV genomes isolated from a renal transplant recipient before
and during end-stage liver disease, we have demonstrated the
largely altered phenotype of the complex variants compared to
wt HBV in HuH7 cells (Märschenz et al., 2006). The variants
showed increased expression of pregenomic RNA, decreased
levels of surface mRNAs, preC mRNA and the major spliced
pregenomic RNA as well as a partial or complete defect in
HBeAg, core and surface protein expression/secretion. When
small amounts of the variants were co-transfected with wt, an
enhanced replication and enrichment of the variants compared
to wt HBV were observed. These alterations and defects support
the supposed role of the variants in pathogenesis.
However, our studies of co-replication of the variants with wt
did not elucidate the consequences of decreasing wt proportions
as detected in vivo or the impact of the enhanced variant repli-
cation on wt replication. Previous studies with artificially con-
structed virus genomes carrying C gene deletions in a genomic
wt HBV background suggested that enhanced replication and
enrichment of C gene deletion variants are accompanied by
simultaneous inhibition of wt replication (Yuan et al., 1998a),
although sometimes only at high variant proportions in the co-
transfection mixture (Günther et al., 2000). C gene deletion
variants were thus classified as defective interfering particles
(Yuan et al., 1998a). The typical Cp mutations of the complex
variants, when analyzed alone within a wt genome context, also
cause enhanced replication by creating new binding sites for
hepatocyte nuclear factor 1 (HNF1) and destroying other nuclear
receptor binding sites (Buckwold et al., 1996; Günther et al.,
1996; Li et al., 1999; Moriyama et al., 1996; Pult et al., 1997). It
remains to be shown, however, whether the consequences of wt
interference and/or variant enhancement by C gene deletions and
the different Cp mutations alone are found with a similar
intensity in the naturally occurring complex variants carrying a
combination of both mutation types.
To shed more light on these open questions, our present
study analyzed the detailed replication properties of different
complex variant genomes (n=6) from two patients with LC.
The replication levels of mixtures containing varying propor-
tions of variant and wt HBV were determined. The influence of
the complex variants on the replication level of wt was ana-
lyzed, as well as the relevance of the combined mutations in Cp
and C gene for the replication phenotype of the mixtures. Co-
replication experiments were performed in 2 different human
hepatoma cell lines (HuH7 and HepG2).
The complex variants showed enhanced replication and
enrichment, mostly independent of the used variant-wt propor-Fig. 1. Detailed schematic presentation of the analyzed complex variants and the wt-
HBV genome with its regulatory sequences and the HBV proteins below (precor
polymerase [P] and X protein [X]) are schematically shown at the top. Abbreviatio
EnhII/Cp: enhancer II/core promoter, BCP: basic core promoter, CURS: core
posttranscriptional regulatory element, E: packaging signal epsilon. For the wt-like g
genome of genotype A (Valenzuela et al., 1980; GenBank No. X02763) are indica
individually in A-S1 or B-S3, all other mutations are found in every HBV genome is
schemes of the 6 complex variants include only exchanges found in addition to
exchanges, rectangles stand for deletions and triangles represent insertions. Below, t
Amino acid count starts at the start codons of precore and core protein, LHBs and Stion. In contrast to genomes with only C gene deletions, the
complex variants did generally not display the characteristic
features of defective interfering particles.
Results
Characterization of the complex variants and experimental
setup
The study was performed with genomes of six different
completely sequenced complex variants. They were isolated and
cloned from serum and liver of two previously described renal
transplant recipients (Preikschat et al., 2002) who developed
liver cirrhosis and end-stage liver disease. The studied variants
are representative of those variants that accumulated during
development of LC in the respective patient and carry the typical
complex mutation pattern with Cp/X gene mutations, C gene
deletions and/or deletions in preS associated with severe liver
disease in renal transplant recipients (Preikschat et al., 2002).
The four variants of patient A (Fig. 1, see also Märschenz et al.,
2006) bear the same in-frame deletions of 90 nucleotides (nt) in
C gene and of 6 nt in preS2. In the Cp, A-S15 and A-S24
additionally have point mutations (at nt positions 1762, 1764; A-
S24 also 1753, 1767), while A-S18 and A-L1 carry an 11-nt
insertion (at position 1776/1777). The two variants of patient B
(Fig. 1) carry an in-frame 51-nt internal C gene deletion, an 8-nt
deletion (nt 1763–1770) and a TNC point mutation at nt 1753 in
Cp (B-S8 additionally at nt 1731 TNC), and a premature stop
codon mutation at amino acid (aa) 74 of S, but no deletions in
preS. The Cp mutations of all variants also result in point mu-
tations (A-S15, A-S24) and premature stops (A-L1, B-S7, B-S8)
in X protein. All clones, especially those from patient A, have
additional point mutations throughout the genome (Fig. 1).
As an experimental model for the in vivo situation of
competitive replication within the cell, the complex variants
were co-transfected with wt virus in different ratios (e.g. 20, 50
or 70% variant DNA in the mixture, while keeping the total
amount of transfected HBV-DNA constant). These ratios reflect
the decreasing wt proportions in the patients during develop-
ment of severe liver disease. Analogous to preceding studies
(Günther et al., 2000; Märschenz et al., 2006), a well-
characterized standard wt genome (Galibert et al., 1979) was
used for the co-transfections. The replication level of wt trans-
fected alone served as reference (=100%) in all experiments.
Replicative intermediates were isolated from intracellular core
particles. The total replication level of co-transfected variants
and wt was determined by Southern blot (Fig. 2A, quantifiedlike clones of patients A and B used for generation of recombinant variants. The
e [preC]/core [C]; large, middle, small surface protein [LHBs/MHBs/SHBs];
ns: S1p: S1 promoter, S2/Sp: S2/S promoter, EnhI/Xp: enhancer I/X promoter,
upstream regulatory sequence, NRE: negative regulatory element, PRE:
enomes of each patient, A-S1 and B-S3, all mutations compared to a reference
ted on the horizontal line. Except for the mutations printed in bold occurring
olated from the respective patient. For simplification, mutations indicated in the
those present in the corresponding wt-like genome. Bars represent nucleotide
heir consequences at amino acid level in the different HBV proteins are shown.
HBs, polymerase and X protein, respectively. fsh: frame shift.
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Fig. 1 (continued ).
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Fig. 2. Southern blot and pyrograms resulting from pyrosequencing reactions. Results for replicative intermediates isolated from HuH7 cells after co-transfection of
variant A-L1 and wt in different ratios. (A) Exemplary Southern blot of replicative intermediates from intracellular core particles after co-transfection of mixtures
containing 20, 50 or 70% variant DNA. HBV marker: 1:1000 dilution of products of an HBV full-length genome asymmetric PCR (3.2-kb double strand [ds] and
single strand [ss] fragments). (B) Exemplary pyrograms obtained by pyrosequencing of replicative intermediates of the same sample used for Southern blotting. The
pyrogram presents the intensity of light emission during the pyrosequencing reaction after consecutive dispension of enzyme (E), substrate (S) and the different
nucleotides indicated at the bottom of each pyrogram. The percentages of nucleotides T (present only in the wt genome) and A (present only in the variant genome) in
the DNA mixture were calculated from the height of the two peaks of the T/A single nucleotide polymorphism (SNP, boxed) by the integrated software (indicated
below). The nucleotides C and G added before and after the T/A-SNP do not bind the DNA and serve as a negative control of unspecific binding. The last 5 nucleotides
are added according to the actual HBV genome sequence following the sequencing primer (quoted above the pyrograms). They serve as control of the entire
pyrosequencing reaction. The pyrosequencing results were normalized to a calibration curve. For further information, see Materials and methods.
251S. Märschenz et al. / Virology 372 (2008) 247–259signals, e.g. in Fig. 3A, top lines). The percentage of variant and
wt progeny DNA in cytoplasmic core particles was measured by
a quantitative single nucleotide polymorphism (SNP) analysis
by pyrosequencing (Fig. 2B). Great advantages of this method
over previously used one-filter three-probe Southern blot
analyses (Yuan et al., 1998a) or a restriction fragment length
polymorphism assay (Günther et al., 2000) are the excellent
accuracy with low standard deviation and the possibility to test
large sample numbers within a very short period of time.
Based on the Southern blot and pyrosequencing results, we
calculated the level of variant replication in the mixtures (e.g.
Fig. 3A, bottom lines). To analyze the impact of the variants on
wt replication levels, it was determined how the levels of variant
or wt progeny DNA in the mixture changed compared to the
amount of originally transfected DNA (e.g. Fig. 3B). The
enrichment of the variant relative to wt in the different mixtures
was analyzed by relating the variant-to-wt ratio in replicativeintermediates (determined by pyrosequencing) to the trans-
fected variant-to-wt ratio (e.g. Fig. 3C and Märschenz et al.,
2006). For further explanations for the calculations, see
Materials and methods.
Co-replication of complex variants and wt in HuH7 cells
Co-transfections of 20, 50 and 70% variant DNA with wt
generally resulted in increased levels of total replication com-
pared to wt alone (Fig. 3A, top lines). Depending on the variant,
maximal total replication occurred at different transfected
variant proportions, most often at 50%. The increased total
replication was mainly due to enhanced variant replication in
the mixture (Fig. 3A, bottom lines, and Fig. 3B). All variants
showed enrichment over wt (Fig. 3C). The extent was generally
independent of the transfected variant-wt ratio. The particular
levels of enhanced total replication, variant replication and
Fig. 3. Replication in HuH7 cells after co-transfection of variant andwt in different ratios. Replicative intermediates from cytoplasmatic core particles were analyzed 4 days after transfection.Means and standard deviations
of at least 3 independent experiments are shown. (A) Total replication of variant and wt (top line, diamond) determined by Southern blot analysis. Signal intensities of single strand HBV DNA relative to the signal of wt
transfected alone (=100%) were plotted versus the proportion of variant DNA in the transfected mixture. The percentage of variant replication level was determined by pyrosequencing allowing calculation of the variant
replication relative towt transfected alone (bottom line, square). (B) Replication level relative to proportion in transfectedDNA: Level of replicative intermediates of wt or variant HBV, respectively, relative towt alone (see
A) divided by the corresponding proportion in the transfected DNAmixture. A replication level equivalent to the transfected DNA=1. (C) Enrichment of variant replicative intermediates in cytoplasm relative to wt HBV.
Enrichment= ([% variant /% wt] replicative intermediates in cytoplasm determined by pyrosequencing) / ([% variant /% wt] in the transfected DNA). For further details, see Materials and methods.
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253S. Märschenz et al. / Virology 372 (2008) 247–259enrichment varied considerably between the variants. Only the
two variants from patient B – which in contrast to variants from
patient A differ only in a few point mutations throughout the
genome (Fig. 1) – showed a very similar replication pattern. As
a control, a wt-like clone (A-S1) isolated from patient A
carrying no deletions/insertions and none of the typical Cp
mutations (Fig. 1) was co-transfected with wt in different ratios.
Wt-like clone A-S1 did not show enhanced replication and
enrichment relative to wt (Fig. 4).
The wt replication level was only rarely negatively influenced
by the variants (Fig. 3B). In most cases, it was either unaffected
or even increased (1.4- to 3-fold, A-S24, B-S7 and B-S8). This
effect was independent of the transfected variant proportion. A
clear inhibition of wt replication was only seen at transfected
variant proportions of 50% and higher for those two variants
displaying very strongly enhanced replication at low amounts of
transfected variant DNA (A-S15 and A-L1, Fig. 3B). At the
same time, the replication level of these variants decreased,
leading also to a reduced total replication.
Consequently, the enrichment of the complex variants gen-
erally resulted from enhanced variant replication. Only in case of
variants with very high replication efficiency (A-S15, A-L1)
suppression of wt contributed to variant enrichment at high
percentages of transfected variant DNA.
Co-replication in HepG2 cells
To investigate the general contribution of host cell factors to
the replication advantage of the variants, co-transfections of wt
and complex variants derived from patient A were also per-
formed in another hepatoma cell line: HepG2.
The results confirm the replication advantage of the complex
variants also in HepG2 cells (Fig. 5). Their replication patterns
with enhanced replication and enrichment generally resembled
the findings in HuH7 cells (Fig. 3). However, at high proportions
of transfected variant DNA, the replication of the variants as well
as of wt (relative to wt alone) was usually more pronounced in
HepG2. Thus, wt replication was mostly not suppressed, but
even increased when variant DNA was transfected at percen-
tages of 50 or more (Fig. 5B). For variant A-S15, this was
contrary to replication in HuH7 where wt replication was sup-Fig. 4. Enrichment of replicative intermediates of wild-type-like clone A-S1
relative to wt in HuH7 cells after co-transfection of A-S1 and wt in different
ratios. Means and standard deviations of 4 independent experiments (n=8) are
shown. For further details see Fig. 3.pressed at high transfected variant proportions (Fig. 3B). In one
case (A-S18), variant replication in HepG2 cells was extremely
low and even weaker than wt replication, so that the variant was
overgrown at all transfected ratios (0.5-fold enrichment,
Figs. 5B and C).
Co-replication of wt and recombinant genomes carrying
variant mutations in wt context
In order to investigate the impact of the combined mutations
in Cp and C gene on the replication patterns of the variants and
wt at the different transfected ratios, we constructed recombinant
C/Cp genomes of all six complex variants. To this end, Cp and C
gene of wt-like clones isolated from the same patient (A-S1 for
patient A, B-S3 for patient B, Figs. 1 and 6A) were replaced by
the corresponding regions of the variants (Fig. 6B).
Upon co-transfection of the recombinant C/Cp-variants with
wt, the mutations in Cp and C gene of all six variants were
sufficient to cause increased replication (Figs. 6C and D) and in
most cases also an enrichment (Fig. 6E). Even more obvious
than for the complex variants, wt replication was mostly not
suppressed but was rather slightly enhanced (1.5- to 3-fold,
Fig. 6D).
Recombinant C/Cp genomes with identical Cp mutations and
C gene deletions showed a similar replication pattern. Thereby,
the replication levels of the two C/Cp-variants with the 11-nt
insertion in Cp (A-S1/S18-C/Cp, A-S1/L1-C/Cp) or the two C/
Cp-variants with the 8-nt deletion in Cp (B-S3/S7-C/Cp, B-S3/
S8-C/Cp) were clearly more enhanced than the replication of the
two C/Cp-variants with point mutations in Cp (A-S1/S15-C/Cp,
A-S1/S24-C/Cp) (Figs. 6C and D).
Note that A-S1/L1-C/Cp did not show the strong inhibition
of wt replication and thus negative feedback on variant and total
replication of the complex variant A-L1 at high variant concen-
trations in the transfected DNA.
For five of the six C/Cp-variants – independent of the length
of the C gene deletion – replication and enrichment were lower
than for the corresponding complex variants (Fig. 3). Only the
C/Cp-variant of A-S18 showed much higher replication and
enrichment than the complex variant, suggesting an inhibitory
effect on replication caused by mutations exclusively present in
the complex variant. The difference between replication of the
recombinant C/Cp genomes and the complex variants was much
more pronounced in case of variants isolated from patient A.
To clarify the contribution of the mutated C gene to the
interference with wt replication found for complex variant A-L1
but not for the corresponding C/Cp-variant, the C gene of variant
A-L1 was introduced separately into the background of wt-like
genome A-S1 (A-S1/L1-C, Fig. 7A andMärschenz et al., 2006).
After co-transfection with wt, recombinant variant A-S1/L1-C
displayed enhanced replication and enrichment only at 20%
transfected variant DNA. This is analogous to complex variant
A-L1, but at a much lower level (2–3-fold instead of 13-fold,
Figs. 7B–D). However, in spite of the lower replication level of
A-S1/L1-C, wt replication was equally suppressed by recombi-
nant genome A-S1/L1-C and complex variant A-L1 at high
variant proportions in the transfected DNA, causing variant and
Fig. 5. Replication in HepG2 cells after co-transfection of variant and wt in different ratios. Replicative intermediates from cytoplasmatic core particles were analyzed 5 days after transfection. Means and minimal/
maximal values for 2 independent experiments are shown. (A) Total replication of variant and wt determined by Southern blot (top line, diamond) as well as variant replication relative to wt alone determined by Southern
blot and pyrosequencing (bottom line, square). (B) Replication level relative to proportion in transfected DNA. (C) Enrichment of variant replicative intermediates relative to wt. For further explanations, see Fig. 3.
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Fig. 6. Replication in HuH7 cells after co-transfection of wt and recombinant C/Cp-variants in different ratios. Replicative intermediates from cytoplasmatic core particles were analyzed 4 days after transfection.
(A) Representative Southern blot of replicative intermediates after transfection of wt and wt-like clones A-S1 and B-S3 isolated from patients A and B, respectively. The 3.2-kb single strand (ss) HBV DNA is shown.
(B) Schematic presentation of C/Cp-variants: Cp and C gene of a wt-like genome isolated from the respective patient (patient A: A-S1, patient B: B-S3) were replaced by the corresponding variant fragments. (C) Total
replication of wt and C/Cp-variant as well as C/Cp-variant replication relative to wt alone. (D) Replication relative to proportion in transfected DNA. (E) Enrichment of C/Cp-variant replicative intermediates relative to
wt. (C, D, E) Means and standard deviations of 3 independent experiments are shown. For further explanations, see Fig. 3.
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Fig. 7. Replication in HuH7 cells after co-transfection of recombinant C gene variant A-S1/L1-C and wt in different ratios. Replicative intermediates from
cytoplasmatic core particles were analyzed 4 days after transfection. Means and standard deviations of at least 4 independent experiments are shown. (A) Schematic
presentation of recombinant C gene variant A-S1/L1-C carrying the C gene of complex variant A-L1 in the backbone of wt-like clone A-S1. (B) Total replication of wt
and A-S1/L1-C as well as replication of A-S1/L1-C relative to wt alone. (C) Replication relative to proportion in transfected DNA. (D) Enrichment of A-S1/L1-C
replicative intermediates relative to wt. For further explanations, see Fig. 3.
256 S. Märschenz et al. / Virology 372 (2008) 247–259total replication to decrease. Thus, the C gene with internal
deletion mediated suppression of wt replication at high variant
proportions, but not in the additional presence of an insertion in
Cp (A-S1/L1-C/Cp, Fig. 6D). Nevertheless, the complex variant
A-L1 with much stronger replication competence showed again
substantial suppression of wt replication (Fig. 3).
Discussion
The present study characterized the replication phenotype of
six defective HBV variant genomes with mutations in Cp/X
gene, deletions in C gene and/or deletions in preS upon co-
transfection with wt HBV. Accumulation and persistence of
such genomes in renal transplant recipients were associated
with severe liver disease (Preikschat et al., 2002). The variants
showed enhanced replication and enrichment during co-
replication with wt in HuH7 as well as in HepG2 cells. The
replication advantage was seen independently of the variant
proportion in the transfection mixture. However, the level of
replication and enrichment differed considerably among the
variants. In most cases, the enrichment of the variants did not
lead to suppression of wt replication.
The replication phenotype of the naturally occurring variants
was more complex than expected from the previous experiments
with artificially constructed variants carrying either Cp muta-
tions or C gene deletions (Buckwold et al., 1996; Günther et al.,
1996, 2000; Pult et al., 1997; Yuan et al., 1998a). For example,
the replication level of the recombinant C/Cp-variant of A-L1
was higher than the sum of the individual effects of Cp mutationand C gene deletion (Figs. 6 and 7 as well as Märschenz et al.,
2006). This suggests a synergistic interaction of both mutations.
The replication and enrichment levels of the recombinant C/Cp-
variants (Fig. 6) correlated with the proposed affinity of the new
HNF1 binding sites created by the different Cp mutations
(strongest for the Cp insertion and weakest for the Cp point
mutations at nt 1762/1764). Contrary to this, the replication level
was shown to be mostly independent of the length of C gene
deletion (Günther et al., 2000). Thus, the enhancement level of
replication largely depends on the nature of the Cp mutation.
Moreover, additional mutations outside of Cp and C gene
influenced the replication phenotype of the complex variants
compared to the corresponding recombinant C/Cp-variants
(Figs. 3 and 6). This was mainly the case for complex variant
genomes of patient A which differ considerably among each
other and show more divergence from the reference wt sequence
than genomes from patient B (Fig. 1). In most cases, the
additional mutations had an enhancing effect on replication;
they suppressed the replication only in one case (A-S18). The
enhancing effect was most obvious for variant A-L1, where
additional mutations acted synergistically with Cp mutation and
C gene deletion in mediating the very high replication capacity.
We previously showed that the enhanced replication of the
variants is mainly caused by an advantage during the reverse
transcription step (Märschenz et al., 2006). This is irrespective
of the transfected variant-to-wt ratio (data not shown).
However, the detailed mechanism remains unclear.
Enhanced replication and enrichment of the complex
variants were observed both in HuH7 and HepG2 cells. Thus
257S. Märschenz et al. / Virology 372 (2008) 247–259the phenomenon was independent of host cell specific factors
unique in only one of the cell lines. However, HepG2 cells
allowed higher replication levels of both variants and wt and
thus less competitive replication at high transfected variant
proportions. Variations like this could have been influenced by
different levels of transcription factors in the two cell lines (Suk
et al., 2002). Several transcription factors (e.g. PPARalpha,
HNF4, HNF1), which often either preferentially promote wt or
variant pregenomic RNA and replication (Tang et al., 2001),
were found to be more abundant in HepG2 than in HuH7 cells
(Yu and Mertz, 2001; M. Quasdorff and U. Protzer, personal
communication).
Only one variant (A-S18) showed much lower replication in
HepG2 than in HuH7 cells. A possible explanation for this
discrepancy might be the defect in X protein expression of this
variant (due to an X start codon mutation; Fig. 1), leading to a
reduced X protein level in the variant/wt co-transfected cells.
The X protein is known to stimulate HBV replication in HepG2
(Bouchard et al., 2003; Melegari et al., 1998, 2005) but not in
HuH7 cells (Blum et al., 1992; Melegari et al., 1998).
In agreement with previous data on artificial genomes
carrying C gene deletions in a wt context (Günther et al.,
2000; Yuan et al., 1998a), our recombinant C gene deletion
variant A-S1/L1-C clearly suppressed wt replication (Fig. 7).
Contrary to this, however, most of the natural complex C gene
deletion variants did not interfere with wt replication (Figs. 3
and 5). Also after co-transfection of wt with mixtures of several
variant genomes, simulating the composition of the natural virus
populations isolated from the two patients (see also Märschenz
et al., 2006), no suppression of wt replication was found (data
not shown). Likewise, interference with wt replication was
almost completely absent after co-transfections with the recom-
binant C/Cp-variants carrying C gene deletions+Cp mutations
(Fig. 6). These data show that the concept of defective interfering
particles for C gene deletion variants (Yuan et al., 1998a) cannot
simply be applied to variants with a complexmutation pattern. In
particular, the Cp mutations seem to counteract the suppressive
effect of C gene deletions on wt replication. Indeed, the presence
of Cp mutations on the same genome appears to be important for
the selection of C gene deletions in vivo: In the patients, variants
with C gene deletions solely emerged if variants with mutations
in only Cp were already present (Preikschat et al., 2002).
The reason for this phenomenon could be the changed
binding of transcription factors to the mutated Cp (for a review
of Cp regulation, see Moolla et al., 2002). All Cp mutations
present in the tested variants do not only create novel HNF1
binding sites but also delete binding sites for other transcription
factors (e.g. PPARalpha-RXRalpha, COUP-TF1 and partially
HNF4alpha; Tang et al., 2001; Yu and Mertz, 2001). Con-
sequently, the Cp mutations largely reduce the competition for
transcription factors during co-replication of variants and wt.
In the hepatoma cells, replication of wt alone is probably
generally restrained by the limited supply of crucial transcription
factors (supported by results comparing hepatoma cell lines to
primary hepatocytes; M. Quasdorff and U. Protzer, personal
communication). After co-transfection of variant-wt mixtures
(in the same total amount as wt alone), a larger portion of thosefactors not binding the variant Cp should therefore have been
available for stimulation of the wt Cp. This may be one ex-
planation for the enhanced wt replication found during co-
replication with the variants (especially at high percentages of
transfected variant DNA).
The relevance of the enhanced replication of defective
complex variants upon complementation with wt for the
pathogenesis of LC is not clear. However, an association
between the high replication capacity of variants and pathogen-
esis has been proposed earlier (Lin et al., 2002), and the data
presented here support this hypothesis. Interestingly, disease
progression and development of LC after accumulation of
complex variants were much slower in patient A than in patient
B (Preikschat et al., 2002). At the same time, the virus popu-
lation in patient A was much more heterogeneous combined
with higher phenotypic variability than in patient B. Thus, one
might also speculate about a correlation between the complexity
of a quasispecies and the severity of the disease.
In conclusion, the natural complex variants display a repli-
cation phenotype that is not simply the sum of the phenotypes
previously observed with artificial genomes carrying either C
gene deletions or Cp mutations. In agreement with the previous
experiments, all natural variants showed enhanced replication
and enrichment at several co-transfection ratios of variant and
wt. However, most of them did not suppress wt replication, an
effect that appears to be mediated by the Cp mutations.
Materials and methods
Patients and full length HBV genomes
HBV genomes (genotype A) were derived from two chron-
ically HBV-infected HBeAg positive renal transplant recipients
(A and B) under long-term immuno-suppression before and
during end-stage liver disease (also described as patients 12 and
8 by Preikschat et al., 2002, for patient A also see Märschenz
et al., 2006). Full length monomers of the HBV genomes from
the patients' sera and liver had been amplified and cloned into
pZErO (Invitrogen, Karlsruhe, Germany) as previously de-
scribed (Günther et al., 1995; Preikschat et al., 2002) and were
completely sequenced (Fig. 1). Four complex variants from
patient A (A-S15, A-S18, A-S24 and A-L1, GenBank accession
nos. DQ788726–DQ788729; Märschenz et al., 2006) and two
complex variants from patient B (B-S7, B-S8, GenBank acces-
sion nos. EF208114 and EF208115) were studied. Additionally,
a wt-like clone from each patient – A-S1 (GenBank accession
no. DQ788725; Märschenz et al., 2006) for patient A and B-S3
(GenBank accession no. EF208113) for patient B – was char-
acterized and used for generation of the recombinant genomes. A
plasmid containing the full-length monomer of a genotype D wt
genome (Galibert et al., 1979) was used as reference.
Construction of recombinant genomes
Recombinant genomes were generated by replacement of C
gene (nt 1820–2331) or Cp and C gene (C/Cp, nt 1450–1820
and 1820–2331) of a wt-like clone isolated from the same
258 S. Märschenz et al. / Virology 372 (2008) 247–259patient (patient A: A-S1, patient B: B-S3) with the correspond-
ing regions of the variants. The cloning procedure was described
in detail by Märschenz et al. (2006). The correct construction of
all recombinant genomes was verified by sequencing.
Transfection
HBV monomers, released from the plasmids by SapI
digestion, were transfected into cells of hepatoma cell lines
HuH7 or HepG2 as described (Märschenz et al., 2006) using
2.2 μl (HuH7) or 6.6 μl (HepG2) ExGen 500 reagent
(Fermentas, St. Leon-Rot, Germany) per μg DNA, according
to the manufacturer's instructions. HBV-DNA of the variants
was co-transfected with wt in different ratios, keeping a constant
total HBV-DNA amount of 2 μg. Medium was changed 4 h
before transfection and for HepG2 additionally 1 day after
transfection. Cells were harvested after 4 (HuH7) or 5 days
(HepG2). Transfection efficiency in every sample was mon-
itored by co-transfection of 1 μg of reporter plasmid expressing
secreted alkaline phosphatase and measurement of its enzymatic
activity in the cell culture supernatant (Cullen andMalim, 1992).
Purification of HBV DNA from cytoplasmic core particles
Purification was performed as described (Günther et al.,
2000) with minor modifications. Briefly, cells were washed
twice with ice-cold PBS and lysed in 1 ml (HuH7) or 600 μl
(HepG2) of lysis buffer (50 mM Tris [pH 8], 1 mM EDTA, 1%
Nonidet P-40) per cell culture dish for 15 min on ice. The lysate
was incubated on ice within Eppendorf tubes for another 15 min
and nuclei were pelleted by centrifugation. After DNase I and
subsequent proteinase K treatment of the supernatant, nucleic
acids were purified by phenol–chloroform (1:1) extraction and
isopropanol precipitation overnight.
Southern blot analyses
DNA isolated from cytoplasmic core particles (1/2 [HuH7]
or 5/6 [HepG2] of the harvest) was subjected to Southern
blotting as described (Märschenz et al., 2006). Blots were
hybridized with a digoxigenin-labeled full-length HBV probe
and bands were quantitatively analyzed with the TINA 2.0
software (Raytest, Straubenhardt, Germany).
Differentiation of wt and variant progenyDNA by pyrosequencing
For determination of the proportion of wt and variant
replicative intermediates in cytoplasmic core particles after co-
transfection, a quantitative single nucleotide polymorphism
(SNP) analysis of nucleotide 1850 (wt=T, variant=A) was
performed by pyrosequencing. This real-time sequencing
technique is based on the detection of stepwise nt incorporation
by luminescence (Lindstrom et al., 2004; Ronaghi, 2001). One
microliter of a 1:20 dilution of each sample (HepG2: undiluted)
was subjected to PCR in a 25 μl reaction with forward primer
5′-AGCAATGTCAACGACCGAC-3′ (nt 1676–1690) and
biotin-labeled reverse primer 5′-biotin-CACAGCTTGGAGG-CTTGAAC-3′ (nt 1862–1881) amplifying HBV replicative in-
termediates but not the transfected linear input DNA. The PCR
(0.5 U Taq, 2 mM MgCl2, 0.2 μM primer forward, 0.2 μM
primer reverse, 0.48 mM dNTPs) was run for 40 cycles with 15 s
at 95 °C, 30 s at 60 °C and 30 s at 72 °C. The entire 205-basepair
PCR product was used for pyrosequencing. For each sample, 3
PCRs and pyrosequencing runs were carried out in parallel with
the SNP Reagent Kit 5×96 and the standard Pyrosequencing
PSQ™ 96 or PSQ™ HS 96A system (Biotage, Uppsala,
Sweden) as described (Uhlmann et al., 2002). Briefly, for sample
preparation, the DNA strands of the PCR product were separated
by means of streptavidin-coupled Dyna beads (Dynal A.S.,
Oslo, Norway) or by sepharose beads and a vacuum prep tool
(HS system). The sequencing primer (5′-CTGCCTAATCATCT-
CTTGT-3′, nt 1831–1849) was hybridized to the biotin-labeled
DNA strand. The sequencing reaction with the specific
nucleotide dispensation order CTAGCATGT (the SNP indicated
in bold) resulted in a pyrogram (Fig. 2B). Peak heights were used
to calculate the percentage of wt (T) and variant (A) DNA in the
mixture with the integrated software. The means of the cal-
culated wt and variant frequencies of each sample were nor-
malized to a calibration curve generated with definedmixtures of
pure wt and variant PCR products.
Calculations
After co-transfection of different wt-variant mixtures, the
level of variant replication relative to the replication level of wt
transfected alone (100%) was calculated by multiplying the
level of total replication (Southern blot) with the variant pro-
portion in replicative intermediates determined by pyrosequen-
cing (Figs. 3A, 5A, 6C, and 7B).
This level of variant replication was then set in relation to the
amount of originally transfected variant DNA by using the
following calculation: % of variant replication in the mixture
relative to wt transfected alone /proportion of transfected
variant DNA (%). The level of wt replication in the mixture
relative to the transfected wt DNA amount was calculated
respectively: % of wt replication level in the mixture relative to
wt transfected alone /proportion of transfected wt DNA (%). A
replication level equivalent to the transfected DNA has a value
of 1 (Figs. 3B, 5B, 6D, and 7C).
As previously described (Märschenz et al., 2006), enrich-
ment of the variant progeny DNA in relation to wt (x-fold) was
calculated by comparison of the variant-to-wt ratio in replicative
intermediates (determined by pyrosequencing) and in the
originally transfected DNA (Figs. 3C, 4, 5C, 6E, and 7D): (%
variant /% wt) replicative intermediates / (% variant /% wt)
transfected DNA. It was assured by pyrosequencing of nuclear
DNA after transfection that the percentages of wt and variant
DNA found in the nucleus correspond to the transfected
percentages (data not shown).
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